Contact This Organization
In an effort to accelerate COVID-19 biomedical discoveries, Omic developed C19.ai. C19 enables collaboration in a virtual lab between computational biologists, data scientists, and health professionals in order to reverse engineer SARS-CoV-2. Omic launched the platform on June 26th and within the first week approximately 100 researchers had joined and formed 9 collaborative projects across multiple computational biology, virology, and AI research areas.
C19.ai connects each of us with the medical and genetic research community to help bring an end to the COVID-19 pandemic.
Type of Organization
Startup - Newly established businesses, investable
Size of Organization
Organization Mailing Address
745A Harvard Ave E
Seattle, WA 98102
COVID-19 AI Analysis Portal
C19 acts as an operating system, with the ability to ingest data into a digital cloud biobank, run SARS-CoV-2 bioinformatics pipelines, design and execute artificial intelligence models with Jupyter notebooks, and run AI-enabled clinical analytics. A high-level technical architecture is shown below.
The effort is organized around five primary research goals:
1. Basic Virology: Understanding the structure,
evolution, infection mechanisms, and host
2. Diagnostics: Detection of the virus, its
components, and neutralizing antibodies;
3. Treatment: Drug discovery and repurposing,
small molecule inhibitors, immunotherapy;
4. Prevention: Passive and induced immunity,
inactivation, and vaccine design;
5. Epidemiology: Emergence, spread, and
related data modeling.
Category of Innovation
Digital Health - A digital health solution is a technology-based solution whose user is caring for or providing care for themselves (think of a personal app) or another individual (such as a doctor using a tool to help their patient)
Intended End User
Provider - Individuals or organizations responsible for providing care to patients (e.g. doctors, nurses, hospital/clinic administrators, etc.)
Startup - newly established business, investable
Problem (i.e. barrier, issue, complication, etc.) being solved for the end user
Since the World Health Organization declared COVID-19 a pandemic in March, academics, governments, and companies have generated numerous and valuable SARS-CoV-2 data and evidence. While altruistic organizations have made substantial progress in organizing open data assets (CORD-19, Shelter in Place Index) and researchers (COVID-19 NSVD, Crowdfight COVID-19), fewer advances have materialized in open, centralized scientific research.